UCLA Clinical and Translational Science Institute
Mission Statement
At a Glance
0
Educational Resources Posted
4
Consortium News Stories Posted
3
Events Posted
0
Opportunities Posted
130
Publications citing CTSA Program Grant
29
Users from Hub Registered
UL1 Award
KL2 Award
TL1 Award
UL1
UL1 Director
UL1 Administrator
Education
KL2 Director
TL1 Director
Communications
Communications Representative
Enterprise Committees
Integration Across Lifespan Voting Member
PeterSzilagyiProfessor and Executive Vice-Chair, Department of PediatricsWorkforce Development Voting Member
Informatics Voting Member
AlexBuiSenior Associate Director for Informatics for UCLA Clinical and Translational Science InstituteCollaboration and Engagement Voting Member
-
AlexBuiSenior Associate Director for Informatics for UCLA Clinical and Translational Science Institute
-
SavannaCarsonAssociate Program Director, Community Engagement and Research Program
-
TonyKuoCo-Program Leader, UCLA Clinical and Translational Science Institute
-
AntoniaPetruseDirector, CTSI- Embedded Clinical Research and Innovation Unit
-
PeterSzilagyiProfessor and Executive Vice-Chair, Department of Pediatrics
Consortium News
In 2017, Jeffrey Bazarian, M.D., M.P.H., a concussion researcher at the University of Rochester Medical Center, wanted to pull together a national network of concussion clinics to run multi-site clinical trials. He turned to the University of Rochester Clinical and Translational Science Institute (UR CTSI) and Trial Innovation Network (TIN) for help and ended up connecting with a group already
Events
Dr. Hwang is an Attending Radiologist within the Division of Body Imaging, Director of Neonatal Imaging, and an Assistant Professor of Radiology at the University of Pennsylvania. Her KL2 project is on the validation of quantitative brain contrast enhanced ultrasound for evaluation of brain health in porcine model and infants of brain injury. Required registration at https://uclahs.fyi/Hwang to
Dr. Steven Hicks, MD, PhD is an Associate Professor of Pediatrics at Penn State University. His translational research identifies molecular biomarkers that inform child growth, neurodevelopment and disease. ABSTRACT: Mild traumatic brain injury (mTBI) is extremely common among adolescents, who suffer disproportionately from prolonged concussion symptoms - a condition for which no biologic test
Please join us for the inaugural California Precision Health Summit Feb. 6-7 at UCLA. The summit will focus on cancer: tumor evolution, liquid biopsies, and immuno-oncology. Featured speakers include: - Christina Curtis, PhD, MSc - Caroline Dive, CBE - Antoni Ribas, MD, PhD - Charles Swanton, FRS, FMedSci, FRCP - Peter Van Loo, PhD Register online by Dec. 14
Poster Sessions
Recognizing the diversity of populations within California and the disproportionate burden of COVID-19 on minority and low income communities, we have formed a statewide community-partnered collaborative funded by the NIH/NHLBI to address disparities in COVID-19 knowledge, awareness, and communication; vaccine trial participation; and vaccine hesitancy and accessibility. The statewide
UCLA CTSI Population Health Program Population health seeks to identify and address variation in needs, care experiences, intervention efficacy, and outcomes for a defined group. In health systems, closing gaps often require collective actions of complex interdependent medical and social care systems in communities. The CTSI co-developed a Population Health Program with the local health department
Publications
A Multi-Dimensional Characterization of Aging and Wellbeing Among HIV-Positive Adults in Malawi
There is relatively little research on aging with HIV and wellbeing in sub-Saharan Africa. A cross-sectional survey was implemented in Malawi; eligible respondents were ≥ 30 years old and on ART for ≥ 2 years. Univariate and multiple regression analyses were stratified by age (younger adults: aged
Treatment outcomes and costs of a simplified antiviral treatment strategy for hepatitis C among monoinfected and HIV and/or hepatitis B virus-co-infected patients in Myanmar
Access to hepatitis C virus (HCV) testing and treatment is limited in Myanmar. We assessed an integrated HIV and viral hepatitis testing and HCV treatment strategy. Sofosbuvir/velpatasvir (SOF/VEL) ± weight-based ribavirin for 12 weeks was provided at three treatment sites in Myanmar and sustained
Occult Colonic Perforation in a Patient With Coronavirus Disease 2019 After Interleukin-6 Receptor Antagonist Therapy
Interleukin-6 blockade (IL-6) has become a focus of therapeutic investigation for the coronavirus disease 2019 (COVID-19). We report a case of a 34-year-old with COVID-19 pneumonia receiving an IL-6 receptor antagonist (IL-6Ra) who developed spontaneous colonic perforation. This perforation occurred